INS PstI polymorphism and prostate cancer in African-American men

Prostate

Volumn 65, Issue 1, 2005, Pages 83-87

  Claeys, Gina B ^a   Sarma, Aruna V ^a,b   Dunn, Rodney L ^a   Zuhlke, Kimberly A ^a   Beebe Dimmer, Jennifer ^a,b   Montie, James E ^a   Wojno, Kirk J ^a   Schottenfeld, David ^a,b   Cooney, Kathleen A ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c 7310 CCGC 0946 ^*  (United States)

Author keywords

African American; INS; Polymorphism; Prostate cancer

Indexed keywords

INSULIN; ENDODEOXYRIBONUCLEASE PSTI; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNOLOGY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INS PSTI GENE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; GENETICS; MIDDLE AGED; PROSTATE TUMOR; RISK;

ADULT; AFRICAN AMERICANS; AGED; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GENOTYPE; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK;

EID: 24944432276     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20271     Document Type: Article

References (11)

1. Brawley OW, Knopf K, Thompson I. The epidemiology of prostate cancer part II: The risk factors. Semin Urol Oncol 1998;16:193-201.
2. Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001. Semin Urol Oncol 2002;20:3-9.
3. Robbins JM, Vaccarino V, Zhang HP, Kasl SV. Excess type 2 diabetes in African-American women and men aged 40-74 and socioeconomic status: Evidence from the Third National Health and Nutrition Examination Survey. J Epidemiol Community Health 2000;54:839-845.
4. Hsing AW, Gao YT, Chua S, Deng J, Stanczyk FZ. Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003;95:67-71.
5. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ. Prostate cancer risk and serum levels of insulin and leptin: A population-based study. J Natl Cancer Inst 2001;93:783-789.
6. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer. Br J Cancer 2002;87:726-728.
7. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate 2002;50:1-3.
8. Ho GY, Melman A, Liu SM, Li M, Yu H, Negassa A, Burk RD, Hsing AW, Ghavamian R, Chua SC. Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer 2003;88:263-269.
9. Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, Heeringa SG, Taylor JM, Wei JT, Montie JE, Schottenfeld D. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology 2001;57:91-96.
10. Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, Bell JI. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993;4:305-310.
11. Heeringa SG, Alcser KH, Doerr K, Strawderman M, Cooney K, Medbery B, Schottenfeld D. Potential selection bias in a community-based study of PSA levels in African-American men. J Clin Epidemiol 2001;54:142-148.